TrademarkOpen
Search / United States / 79429604

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

COMPASS

Suspended
Suspension Letter - Mailed
Used for: Nutritional and nutraceutical supplements formulated to support ocular health, slow disease progression, and enhance…
Show more

Class 5: Nutritional and nutraceutical supplements formulated to support ocular health, slow disease progression, and enhance retinal function, particularly for individuals diagnosed with late-stage macular disease or age-related macular degeneration (AMD).
Class 9: Downloadable software leveraging artificial intelligence (AI) algorithms for capturing, analyzing, and monitoring retinal images to assess disease progression, generate personalized treatment recommendations, and facilitate clinical decision-making; scientific and laboratory apparatus (not for direct clinical use) for collecting, interpreting, and managing research data related to ophthalmic treatments and disease models.
Class 10: Minimally invasive laser-based apparatus for the treatment and management of late-stage macular disease, age-related macular degeneration (AMD), and low central vision, designed to improve or maintain visual acuity and patient quality of life; diagnostic instruments and devices, including handheld or wearable artificial intelligence (AI)-powered tools, for detecting, monitoring, and analyzing ocular conditions such as macular degeneration and other retinal disorders (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); interventional medical devices tailored to stabilize or restore sight in individuals suffering from low vision due to advance…
Class 40: Custom manufacturing of ophthalmic devices, laser-based treatments, diagnostic equipment, and related components for third parties, ensuring adherence to quality, safety, and regulatory standards (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).
Class 41: Arranging and conducting seminars, webinars, workshops, and training programs for healthcare professionals and researchers on diagnosing, treating, and managing late-stage macular disease, age-related macular degeneration (AMD), and associated retinal conditions; publishing and distributing printed and electronic educational materials on best practices for ocular health maintenance, preventative eye care, and implementation of artificial intelligence (AI)-driven diagnostic and therapeutic approaches.
Class 42: Clinical and scientific research in the field of ophthalmology, focusing on the development, validation, and optimization of laser-based therapies, diagnostic devices, and minimally invasive interventions for retinal diseases; research and development (R&D) services aimed at advancing artificial intelligence (AI)-driven healthcare solutions, including predictive modeling, disease progression tracking, and outcome measurement in macular disease; providing online, non-downloadable software (SaaS/PaaS) with artificial intelligence (AI)-enabled analytics to support clinical decision-making, real-time patient monitoring, and health data management for improved vision care outcomes; technical cons…
Class 44: Providing minimally invasive ocular treatments, including laser-based therapies, to improve or stabilize visual acuity in patients with late-stage macular disease; telehealth and remote patient monitoring services that utilize artificial intelligence (AI)-driven platforms to guide clinical evaluations, detect disease changes, and optimize treatment regimens for individuals with low central vision; medical consultancy to physicians, clinics, and healthcare institutions on the adoption and integration of laser therapy, artificial intelligence (AI)-empowered diagnostic tools, and evidence-based nutraceutical protocols for retinal disease management.

Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 10 – Medical apparatusClass 40 – Materials treatmentClass 41 – Education & entertainmentClass 42 – Technology & SaaSClass 44 – Medical & beauty services

Status timeline

  1. 7 Aug 2025
    Application received from the International Bureau (Madrid)
    Sn Assigned For Sect 66a Appl From Ib
  2. 15 Aug 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 18 Aug 2025
    Office action issued
    Non-Final Action Written
  4. 30 Mar 2026
    Response to office action filed
    Teas Response To Office Action Received
  5. 3 Apr 2026
    Examination suspended
    Suspension Letter Written
All 15 events
2026-04-03Suspension Letter Written
2026-04-03Letter Of Suspension E-Mailed
2026-04-03Notification Of Letter Of Suspension E-Mailed
2026-04-01Teas/Email Correspondence Entered
2026-03-30Teas Response To Office Action Received
2026-03-30Correspondence Received In Law Office
2025-10-18Refusal Processed By Ib
2025-09-30Request For Reinstatement Received
2025-09-30Non-Final Action Mailed - Refusal Sent To Ib
2025-08-19Non-Final Action (Ib Refusal) Prepared For Review
2025-08-18Non-Final Action Written
2025-08-15Assigned To Examiner
2025-08-14New Application Office Supplied Data Entered
2025-08-14Application Filing Receipt Mailed
2025-08-07Sn Assigned For Sect 66a Appl From Ib

Goods & services by class

Class 5 Pharmaceuticals & supplements

Nutritional and nutraceutical supplements formulated to support ocular health, slow disease progression, and enhance retinal function, particularly for individuals diagnosed with late-stage macular disease or age-related macular degeneration (AMD).

Class 9 Software, electronics & scientific

Downloadable software leveraging artificial intelligence (AI) algorithms for capturing, analyzing, and monitoring retinal images to assess disease progression, generate personalized treatment recommendations, and facilitate clinical decision-making; scientific and laboratory apparatus (not for direct clinical use) for collecting, interpreting, and managing research data related to ophthalmic treatments and disease models.

Class 10 Medical apparatus

Minimally invasive laser-based apparatus for the treatment and management of late-stage macular disease, age-related macular degeneration (AMD), and low central vision, designed to improve or maintain visual acuity and patient quality of life; diagnostic instruments and devices, including handheld or wearable artificial intelligence (AI)-powered tools, for detecting, monitoring, and analyzing ocular conditions such as macular degeneration and other retinal disorders (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); interventional medical devices tailored to stabilize or restore sight in individuals suffering from low vision due to advance…

Class 40 Materials treatment

Custom manufacturing of ophthalmic devices, laser-based treatments, diagnostic equipment, and related components for third parties, ensuring adherence to quality, safety, and regulatory standards (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).

Class 41 Education & entertainment

Arranging and conducting seminars, webinars, workshops, and training programs for healthcare professionals and researchers on diagnosing, treating, and managing late-stage macular disease, age-related macular degeneration (AMD), and associated retinal conditions; publishing and distributing printed and electronic educational materials on best practices for ocular health maintenance, preventative eye care, and implementation of artificial intelligence (AI)-driven diagnostic and therapeutic approaches.

Class 42 Technology & SaaS

Clinical and scientific research in the field of ophthalmology, focusing on the development, validation, and optimization of laser-based therapies, diagnostic devices, and minimally invasive interventions for retinal diseases; research and development (R&D) services aimed at advancing artificial intelligence (AI)-driven healthcare solutions, including predictive modeling, disease progression tracking, and outcome measurement in macular disease; providing online, non-downloadable software (SaaS/PaaS) with artificial intelligence (AI)-enabled analytics to support clinical decision-making, real-time patient monitoring, and health data management for improved vision care outcomes; technical cons…

Class 44 Medical & beauty services

Providing minimally invasive ocular treatments, including laser-based therapies, to improve or stabilize visual acuity in patients with late-stage macular disease; telehealth and remote patient monitoring services that utilize artificial intelligence (AI)-driven platforms to guide clinical evaluations, detect disease changes, and optimize treatment regimens for individuals with low central vision; medical consultancy to physicians, clinics, and healthcare institutions on the adoption and integration of laser therapy, artificial intelligence (AI)-empowered diagnostic tools, and evidence-based nutraceutical protocols for retinal disease management.

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 4 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.